In intrahepatic cholangiocarcinoma, syndecan-1 H-score had no significant influence on recurrence-free survival, although KRAS-mutation status had an influence on recurrence-free survival in cholangiocarcinoma of the cBioPortal cholangiocarcinoma cohort. Here, KRAS is linked to intrahepatic cholangiocarcinoma.